An ambulatory infusion system and a method of operating including a disposable infusion cartridge having a collapsible reservoir and a substantially rigid shell disposed over the collapsible reservoir having an interior volume, a pump device, a pressure sensor in communication with the interior volume and a processor. The method includes actuating the pressure sensor to take pressure measurements at regular time intervals; periodically assessing a preselected number of the pressure measurements with statistical analysis to identify statistical measures associated with the pressure measurements; and using the statistical measures to assess the status of the flexible reservoir and the pump device.
|
1. An ambulatory infusion system, comprising:
an infusion cartridge, the infusion cartridge including a collapsible reservoir for containing a fluid and a substantially rigid shell disposed over the collapsible reservoir and forming an interior volume between an outside surface of the collapsible reservoir and an inside surface of the shell;
a pump device configured to selectively receive the infusion cartridge and cooperate with the infusion cartridge to deliver fluid from the reservoir to the patient;
a pressure sensor located in one of the infusion cartridge and the pump, the pressure sensor in communication with the interior volume of the infusion cartridge; and
a processor located in one of the infusion cartridge and the pump, wherein the processor is programmed with an algorithm to perform the following:
actuating the pressure sensor to take pressure measurements at regular time intervals;
periodically assessing a preselected number of the pressure measurements with statistical analysis to identify statistical measures associated with the pressure measurements including determining a standard deviation for the preselected number of the pressure measurements;
using the standard deviation to assess the status of the flexible reservoir and the pump device including identifying occasions wherein the standard deviation varies substantially from an expected standard deviation; and
associating the occasions wherein the standard deviation varies substantially from an expected standard deviation with the flexible reservoir being filled to or near its maximum level or capacity.
5. An ambulatory infusion system, comprising:
an infusion cartridge, the infusion cartridge including a collapsible reservoir for containing a fluid and a substantially rigid shell disposed over the collapsible reservoir and forming an interior volume between an outside surface of the collapsible reservoir and an inside surface of the shell;
a pump device configured to selectively receive the infusion cartridge and cooperate with the infusion cartridge to deliver fluid from the reservoir to the patient;
a pressure sensor located in one of the infusion cartridge and the pump, the pressure sensor in communication with the interior volume of the infusion cartridge; and
a processor located in one of the infusion cartridge and the pump, wherein the processor is programmed with an algorithm to perform the following:
actuating the pressure sensor to take pressure measurements at regular time intervals;
periodically assessing a preselected number of the pressure measurements with statistical analysis to identify statistical measures associated with the pressure measurements including determining a standard deviation for the preselected number of the pressure measurements;
using the standard deviation to assess the status of the flexible reservoir and the pump device including identifying occasions wherein the standard deviation varies substantially from an expected standard deviation; and
associating the occasions wherein the standard deviation varies substantially from the expected value as being indicative of external factors including transient temperature changes and mechanical pressure being applied to the disposable infusion cartridge.
2. The ambulatory infusion system as claimed in
wherein the processor is further programmed to:
command movement of the main section and the distal section to a ready to dispense position;
assess the statistical measures during a time following the movement of the main section and the distal section to a ready to dispense position including determining the standard deviation for a plurality of time periods following a plurality of movements of the main section and the distal section to a ready to dispense position.
3. The ambulatory infusion system as claimed in
present a message that the flexible reservoir is filled to or near its maximum level or capacity upon identifying an occasion wherein the standard deviation varies substantially from the expected standard deviation.
4. The ambulatory infusion system as claimed in
associate the flexible reservoir being filled to or near its maximum level or capacity with a risk that autodispensing may occur.
6. The ambulatory infusion system as claimed in
reject the pressure measurements made on the occasions wherein the standard deviation varies substantially from the expected value when determining fluid volume in the cartridge from the pressure measurements.
7. The ambulatory infusion system as claimed in
assign the pressure measurements made on the occasions wherein the standard deviation varies substantially from the expected value a lesser weight than pressure measurements taken when the standard deviation is near the expected value when determining fluid volume in the cartridge from the pressure measurements.
|
The invention relates generally to infusion pumps that are utilized for example, in the treatment of diabetes. More particularly, the invention relates to infusion pumps that include a spool, a spool distal section, a collapsible reservoir, a vented volume and a pressure sensor and a controller in the design.
Certain infusion pumps, particularly certain ambulatory insulin infusion pumps that are used to treat people having diabetes, include a spool with a distal section, a collapsible reservoir that contains insulin, vented volume surrounding the collapsible reservoir and a pressure sensor that senses the pressure within the vented volume. The pressure sensor is coupled to a controller or processor that is programmed with an algorithm to control, operate and monitor the infusion pump. The pressure sensor can be used to determine the fluid volume in the collapsible reservoir of the system. In such cases, pressure measurements are taken at intervals and variations in air pressure are used to calculate fluid volume within the collapsible reservoir.
One of the challenges of using the pressure sensor to determine fluid volume in the infusion pump system is that the related calculations are generally made under the assumption that the vented volume air pressure and the fluid pressure in the collapsible reservoir are the same. This assumption is not always true. This is due, for example, to the fact that the collapsible reservoir is not infinitely flexible, especially when it is filled to maximum or near maximum capacity. When the collapsible reservoir is filled to maximum capacity, the envelope of the collapsible reservoir is placed under stress and there can be variations between the pressure inside of the collapsible reservoir and the vented volume surrounding the collapsible reservoir. In the case of the collapsible reservoir being at or near maximum capacity, any compliance in the system, such as, e.g., air bubbles in the fluid or expansion of the fluid-containing structure that does not affect air chamber volume, can cause errors in the fluid volume measurement process as fluid that is removed from the collapsible reservoir in the system will not cause an equal change in air volume of the air in the air chamber.
The invention generally relates to ambulatory infusion devices and is particularly useful in ambulatory infusion devices used in the treatment of diabetes. Examples of such devices and various features that can be associated with such devices include those disclosed in U.S. patent application Ser. Nos. 13/557,163, 12/714,299, 12/538,018, U.S. Provisional Patent Application No. 61/655,883, U.S. Provisional Patent Application No. 61/656,967 and U.S. Pat. No. 8,287,495, each of which is incorporated herein by reference.
Certain infusion pumps, particularly, e.g., certain ambulatory insulin pumps that are used to treat people having diabetes, include a spool with a distal section, a collapsible reservoir that contains insulin, vented volume surrounding the collapsible reservoir and a pressure sensor that senses the pressure within the vented volume. The pressure sensor is coupled to a controller or processor that is programmed with an algorithm to control, operate and monitor the infusion pump. The pressure sensor can be used to determine the fluid volume in the collapsible reservoir of the system.
In the case of a collapsible reservoir being filled to or near to its maximum level or capacity, when the spool moves to the ready to dispense (RTD) position, there is a period of time after the move during which pressure readings indicating the pressure within the vented volume are variable before the pressure readings stabilize. This phenomenon has been observed to be significantly more pronounced in the case of a maximally-filled collapsible reservoir. Furthermore, this phenomenon can be detected by taking pressure readings directly after the spool move and observing the variability of the pressure readings such as by calculation of the standard deviation of the mean of the pressure reading samples as compared to the standard deviation of the pressure reading(s) sampled under other conditions.
One possible explanation for this phenomenon is that adiabatic heating and cooling of the fluid within the pump may occur. Adiabatic heating and cooling occur when, in a thermodynamically isolated system such as may be approximated by this system within the pump, a fluid experiences changes in pressure and the temperature of the fluid changes without any heat transfer taking place between the system and its surroundings.
According to one embodiment of the invention, detection of the vented volume pressure variation, or detection of pressure fluctuation followed by the relative stabilization of the pressure using, e.g., the air pressure sensor, is used to determine if the collapsible reservoir has attained a maximally-filled state.
According to the invention, these variations in vented volume pressure can also be utilized in potentially advantageous ways to estimate when the collapsible reservoir is full or near full, for occlusion detection, for fluid reservoir pressure assessment and for minimum prime amount determination. The observation of pressure may also be useful for determining other factors. In particular, there is a potential to avoid false occlusion detection that occurs due to a phenomenon known as “autodispensing”. Autodispensing will be further discussed herein below.
According to an example embodiment of the invention, the estimation of the fluid volume may be impacted by external factors including temperature change transients and mechanical pressure that might be applied to the rigid container that encloses the vented volume as well as other factors. Measurement and identification of the variance in the pressure signals due to these external influences may be utilized to detect and identify external influences and presents an opportunity to reject these as misleading measurements or at least to, e.g., assign them a lower decision weight when using them to filter out such influences that may otherwise give false readings of dispense volume and other related measurements.
According to an embodiment, an infusion pump for dispensing a quantity of liquid has a spool, spool distal section, collapsible reservoir, vented volume and a pressure sensor. During normal operation, when the spool is moved, the spool distal section remains stationary and fluid is dispensed from the pump, through the patient infusion line and, ultimately, to the patient. If the collapsible reservoir is filled to or near its maximum level or capacity, the envelope of the collapsible reservoir will be under tension, and the fluid pressure of the collapsible reservoir may be high enough to result in a force on the spool distal section which exceeds the friction force between the spool distal section seal and the bore. In this case, the spool distal section will move toward the spool and there will be an “auto-dispense”, or unintended dispensing of a volume of insulin, from the pump into the patient infusion line.
According to another embodiment of the invention, the air pressure in the vented volume is monitored by the pressure sensor directly before a movement of the spool at the ready to fill (RTF) position and RTD position as well as directly after a dispense move of the spool at each of the RTD and RTF positions. Pressure measurements can be made at the ready to fill position as well as at the filled position prior to beginning movement to the ready to dispense position. Thus, four pressure average measurements are recorded, one during a period before the spool is located at the RTF position, one after the spool is located at the RTF position and one each before and after the spool is at the RTD position. Thus, according to the invention, three volume measurements can be calculated by comparison of the four pressure measurements. By comparison of some or all of the three volume measurements the present invention determines if autodispensing did occur. Comparison of the volume measurements is well-suited for fill estimation of the collapsible reservoir, occlusion detection, fluid reservoir pressure assessment and minimum prime amount determination as well as other factors. Embodiments of the invention are also well-suited to avoid false occlusion detection due to autodispensing. Each pressure measurement is an average pressure measurement based on a series of momentary pressure measurements that are taken at short intervals and averaged periodically. For example, according to one embodiment, momentary pressure measurements are taken at a rate of eight per second and averaged for each second. Various conditions can be inferred from statistical analysis of these momentary pressure measurements, including but not limited to the collapsible reservoir being filled to or near to maximum capacity and whether autodispensing has occurred or is likely to occur.
Sequential air pressure measurements can be made by a pressure sensor that is in fluid communication with the vented volume in which the collapsible reservoir is housed. Air pressure measurements can be made regularly over a defined period of time within which period the average air pressure within the vented volume is taken periodically. These pressure samples can also be subjected to other statistical analyses. For example, according to one example embodiment of the invention, air pressure measurements are made at a rate of eight hertz (eight samples per second) and averaged each second.
The controller of the insulin pump, according to an embodiment, can be programmed to identify a standard deviation of the air pressure measurements over the selected period of time. For example, the average air pressure measurement may be taken at a rate of eight measurements per second and the standard deviation of the eight pressure measurement calculated as well. These values are exemplary and should not be considered limiting.
Accordingly, when the collapsible reservoir is filled to its maximum volume, advantage can be taken of the fact that there is a period of time directly after the movement of the spool during which the pressure is variable and finally stabilizes. Thus, according to the present invention the point at which the collapsible reservoir is filled to a maximum level or to about a maximum level can be identified by analyzing the standard deviation of a particular time period for sampling of air pressure. If the standard deviation in air pressure during the time period exceeds a threshold value it can be inferred that the collapsible reservoir is filled to or near its maximum level or capacity.
Thus, having captured this information, it is possible for the controller of the insulin pump to identify a filled state of the collapsible reservoir as well as detection of a false indication of an infusion obstruction if the collapsible reservoir is fully filled and autodispensing has occurred.
Further, the estimation of fluid volume can be altered by external influences such as temperature transients and mechanical pressure on the exterior of the rigid container that houses the vented volume. Measurements of the variance of pressure signals that are not associated with a collapsible reservoir that is filled may be used, according to an embodiment, to detect these internal influences and either reject measurements that are associated with them or assign the measurements associated with high variance a lower weight in the analysis process.
With regard to detection of autodispensing, according to an embodiment, when the spool and spool distal section are in the ready to fill (RTF) position, a pressure measurement can be taken by the pressure sensor. After the spool has transitioned from the RTF to the filled position, another pressure measurement is taken via the pressure sensor. Under normal conditions the volume of the collapsible reservoir will have decreased and the pressure within the air chamber will have dropped. The spool will then continue moving to the ready to dispense (RTD) position. During this time period, pressure measurements would continue to drop as insulin leaves the collapsible reservoir to fill in the space behind the spool distal section as the spool and spool distal section move from the filled position to the RTD position. While the spool and spool distal section are at rest in the RTD position, pressure within the air chamber under most circumstances will remain approximately constant. However, if the collapsible reservoir is filled at or near capacity and the envelope of the collapsible reservoir is under tension, a phenomenon known as “autodispensing” may occur. In the case of autodispensing, pressure of the fluid behind the spool distal section overcomes the frictional resistance of the spool distal section Seal, causing the spool distal section to move toward the spool, thus “autodispensing” a measured quantity of insulin. At this point, there is a reduction in pressure within the collapsible reservoir as the spool distal section moves toward the spool. This otherwise unexpected drop in pressure then can be identified as the result of autodispensing having occurred. Further, if autodispensing has not occurred, if the dispensing command is given and the spool moves toward the spool distal section normally there would be no change in pressure in the collapsible reservoir or the vented volume because the spool distal section remains stationary. In the case in which autodispensing has already occurred, there is a rise in pressure in the collapsible reservoir and a consequent rise in pressure in the air chamber, thus indicating that autodispensing has previously occurred. This can be used to confirm an earlier observation of autodispensing.
According to one embodiment of the invention, an alarm signal or message can be sent to the screen of the insulin pump to advise the patient that the collapsible reservoir has been filled to or near its maximum level or capacity and that autodispensing has occurred because of this phenomenon. The patient or caregiver then has the opportunity to take these issues into account at future fillings of the collapsible reservoir. The patient or caregiver can then take steps to avoid maximal filling of the collapsible reservoir.
According to an embodiment of the invention, a first pressure measurement is taken when the spool and distal section are at the RTF or filled position. This pressure is designated P1 also designated Prtf in Equation 1). The spool and distal section are then moved to the RTD position. This movement causes a change in volume referred to as Delta V1. A second pressure measurement is then taken when the spool and distal section are at the RTD position. This pressure is designated P2 (also designated Prtd in Equations 1 and 3). The spool is then moved from the RTD position to the dispensed position. This movement causes a change in volume referred to as Delta V2. A third pressure measurement is taken at the dispensed position. This pressure is designated P3 (also designated Pdispensed in Equation 3). The spool and distal extension are moved from the dispensed position back to the RTF position. A fourth pressure measurement is taken at the RTF position. This pressure is designated P4 (also designated Prtf in Equation 3).
With knowledge of the estimated pressures and volume changes, various calculations can be made.
A first estimate of air volume in the vented volume can be estimated from P1, Delta V1 and P2. Once the air volume is known, fluid volume within the collapsible reservoir, fluid passages and the bore can be estimated by subtraction of the air volume from the total known volume. The resulting fluid volume is designated Volume estimate1.
Wherein 4100 μl is the assumed air volume of the system when the collapsible reservoir is empty.
If the second pressure equals the third pressure (P2=P3) the infusion pump is operating properly because during normal dispensing the spool distal section remains stationary during dispensing. If the second pressure is less than the third pressure (P2<P3) it can be inferred that either there is an occlusion in the fluid dispensing port or line or that autodispensing has occurred. This is because the spool distal section has moved distally thus increasing P3.
A second estimate of air volume in the vented volume can be estimated from P3, Delta V2 and P4. Once the air volume is known, fluid volume within the collapsible reservoir, fluid passages and the bore can be estimated by subtraction of the air volume from the total known volume. The resulting fluid volume is designated Volume estimate2.
Based on the above information the following can be estimated:
According to another embodiment, a persistence filter is included in the method so that the process is repeated a number of times before a determination is made that autodispensing has occurred or that an occlusion exists. If the process is repeated the designated number of times and it is estimated that autodispensing has occurred or that an occlusion exists the method includes presenting a message, alarm or warning that that autodispensing has occurred or that an occlusion exists as appropriate.
Provided herein are systems, devices and methods for detecting auto dispensing and false signals related to temperature transients and mechanical forces applied to the infusion cartridge as well as detection of whether a collapsible insulin reservoir is at or near its maximum capacity in an infusion pump and particularly in an insulin pump. Some embodiments may include advances in the internal components, the control circuitry, and improvements in a user interface of the systems and devices. The advances may allow for a safer and more accurate delivery of medicament to a patient than is currently attainable today from other devices, systems, and methods. Although embodiments described herein may be discussed in the context of the controlled delivery of insulin, delivery of other medicaments as well as other applications are also contemplated. Device and method embodiments discussed herein may be used for pain medication, chemotherapy, iron chelation, immunoglobulin treatment, dextrose or saline IV delivery, or any other suitable indication or application. Non-medical applications are also contemplated.
The cartridge 112 may be releasably and operatively secured to a housing 124 of the pump device 114. The housing 124 may be configured to house a drive mechanism 150 including a motor 152 and gear box 154 disposed in the housing 124 and detachably coupled to a spool member 156 of the delivery mechanism 132. At least one pressure sensor 158 may be disposed in a volume 160 between an outside surface 162 of the flexible material or membrane 128 of the collapsible reservoir 126 and an inside surface 164 of the substantially rigid shell or case 130. The graphic user interface 116 may be operatively coupled to a controller 168, which may include at least one processor 170, a memory device 172 and connective circuitry or other data conduits that couple the data generating or data managing components of the device. A power storage cell in the form of a battery 174 that may be rechargeable may also be disposed within the housing 124. Data generating or managing components of the device may include the processor(s) 170, the memory device 172, sensors 158, including any pressure or temperature sensors, the GUI 166 and the like.
The pressure inside the infusion cartridge 112, and particularly the vented volume 160 of the infusion cartridge 112, may be measured by a pressure sensor 158 disposed in the infusion cartridge 112 or in the pump device 114 in a volume, such as pocket 186 as shown in
The pump device 114 can also include a thermistor or other temperature sensor 188 including an optical or infrared sensor that measures the temperature of the insulin or other medicament within the reservoir 126 upon coupling the infusion cartridge 112 with the pump device 114. Taking the temperature of the air may be important in measuring how much insulin or other medicament is in the fluid reservoir. In some embodiments, the thermistor or other temperature sensor 188 is positioned in the pocket 186 such that it can measure the temperature of the air in the pocket 186 as shown in
Referring to
Referring again to
The collapsible first volume 244 of the delivery mechanism 132 may be positionable to overlap the reservoir inlet port 138 independent of an overlap of the fluid dispense port 142. The collapsible first volume 244 may be formed between a first seal 248 around the spool 156, a second seal 250 around the spool, an outer surface of the spool body between the first and second seal 250 and an interior surface 252 of the bore 220 between the first and second seal 248 and 250. The first and second seals 248 and 250 are axially moveable relative to each other so as to increase a volume of the collapsible volume 244 when the first and second seals 248 and 250 are moved away from each other and decrease the collapsible volume 244 when the seals 248 and 250 are moved closer together.
The second seal 250 is disposed on a main section 254 of the spool 156 of the delivery mechanism 132 and moves in conjunction with movement of the rest of the spool. A proximal end 196 of the spool 156 is coupled to a ball portion 194 of a drive shaft 190 of the drive mechanism 150 of the pump device 114. The drive mechanism 150 includes a rack and pinion 192 mechanism actuated by an electric motor 152 through a gear box 154. As such, the second seal 250 moves or translates axially in step with axial translation of the spool 156 and drive shaft 190. The first seal 248, however, is disposed on a distal section 258 of the spool 156 which is axially displaceable with respect to the main section 254 of the spool 156. The distal section of the spool 156 is coupled to the main section of the spool by an axial extension 260 that is mechanically captured by a cavity 261 in the main section 254 of the spool 156. This configuration allows a predetermined amount of relative free axial movement between the distal section 258 of the spool and the nominal main section 254 of the spool 156.
For some embodiments, a volume of a “bucket” of fluid dispensed by a complete and full dispense cycle of the spool 156 may be approximately equal to the cross section area of the bore 220 multiplied by the length of displacement of the captured axial extension of the spool 156 for the distal section 258. The complete bucket of fluid may also be dispensed in smaller sub-volumes in increments as small as a resolution of the drive mechanism 150 allows. For some embodiments, a dispense volume or bucket defined by the complete collapsible volume 244 of the delivery mechanism 132 may be divided into about 10 to about 100 sub-volumes to be delivered or dispensed. In some cases, the maximum axial displacement between the distal section and main section of the spool may be about 0.01 inch to about 0.04 inch, more specifically, about 0.018 inch, to about 0.022 inch.
In use, once the reservoir cartridge 112 of the infusion pump system 110 has been installed or otherwise snapped into place in the slot 122 of the pump device 114, the interior volume 140 of the collapsible reservoir 126 may then be filled with a desired fluid 121 for dispensing. In order to fill the reservoir 126, the spool 156 may be translated by the drive mechanism 150 to a hard stop position 226 as shown in
A reservoir fill port 134 is disposed on a top portion of the bore 220 substantially opposite the bore 220 of the reservoir inlet port 138. With the spool 156 and seals 248, 250, 262 and 264 thereof so positioned, a patient may then obtain an amount of a desired fluid to be dispensed. In some cases, if the desired fluid to be dispensed is insulin or other suitable medicament, the patient 127 typically stores the insulin in a refrigerated glass container. The insulin is then accessed with a hypodermic needle 222 of a syringe device and drawn into an interior volume of the syringe (not shown). The tip of the hypodermic needle 222 of the syringe may then be pushed through a septum membrane 136 that seals the reservoir fill port 134 as shown and fluid manually dispensed from the interior volume of the syringe, through the hypodermic needle 222, through a bubble trap volume 314 in the bore 220 of the delivery mechanism 132 and into the interior volume 140 of the collapsible reservoir 126 of the cartridge 112 as shown by the arrow 318 in
As discussed above with regard to other embodiments of the delivery mechanism 132, the vented volume 160 of the cartridge 112 disposed between an outside surface 162 of the flexible membrane 128 of the collapsible reservoir 126 and an inside surface 164 of the rigid shell 130 may include or be in operative communication with a pressure sensor 158. The pressure sensor 158 may be used to monitor the pressure within the vented volume 160 during the filling of the collapsible reservoir 126. The controller 168 of the pump system 114 may be programmed with information regarding the fixed volume of the rigid shell 130 of the cartridge 112 and configured to calculate the volume of fluid loaded into the collapsible reservoir 126 based on the pressure rise within the rigid shell 130 upon filling of the collapsible reservoir 126. The data regarding the volume of fluid loaded into the collapsible reservoir 126 may be stored and used to calculate and display data later in the use cycle such as fluid remaining in the collapsible reservoir 126 and the like.
Once the collapsible reservoir 126 contains a desired amount of a fluid 121 to be dispensed, a dispense cycle may be initiated by driving the spool 156 with the drive mechanism 150 based on commands from a controller 168 of the pump device to a position with the collapsible first volume 244 in communication with the reservoir inlet port 138. The hard stop position depicted in
The collapsible volume 244 of the delivery mechanism 132 may be completely filled by proximally retracting the main section 254 and second seal 250 of the spool 156 relative to the first seal 248 and distal section 258 of the spool 156 as shown by arrow 322 on spool 156 in
Once filled, the spool 156 and filled collapsible volume 244 may be proximally displaced with the drive mechanism 150 to a position with the collapsible first volume 244 in communication with the fluid dispense port 142 of the bore 220 as shown in
The invention includes devices and methods for detecting auto dispensing and false signals related to temperature transients and mechanical forces applied to rigid container 130 cartridge as well as detection of whether collapsible reservoir 126 is at or near its maximum capacity. The methods may be implemented by processor 170 that has been programmed with an algorithm to perform the methods as described herein. Generally, processor 170 is included in an ambulatory infusion device but can be remotely located and in operable communication with the ambulatory infusion device, for example, by wireless communication.
Referring particularly to
In some circumstances, generally when collapsible reservoir 126 is filled to or near its maximum level or capacity and the flexible walls of collapsible reservoir 126 are under tension, excess pressure in collapsible reservoir 126 may overcome the frictional resistance to movement between bore 220 and distal section 258. In this event, distal section 258 moves toward main section 254 and fluid within collapsible first volume 244 is discharged through fluid dispense port 142. This is an undesirable event. When this event has occurred, it is said that “autodispensing” has occurred. Autodispensing causes a “bucket volume” of insulin or other fluid to be discharged when it is not intended to be discharged. Accordingly, detection of autodispensing is another aspect of the invention.
Pressure sensor 158 is used to sense pressures at regular time intervals based on air in volume 160. Autodispensing generally occurs when collapsible reservoir 126 is filled to or near its maximum level or capacity. The inventors have observed that when spool 156 moves to the RTD position, there is a period of time after the move during which pressure readings of pressure sensor 158 are variable. After spool 156 is in the RTD position for a period of time, the pressure readings stabilize. The inventors have observed that this phenomenon is significantly more pronounced in the case of a filled to or near its maximum level or capacity collapsible reservoir 126 than a partially filled collapsible reservoir 126 and can be detected by taking and evaluating pressure measurements immediately after the move to the ready to dispense position. A series of pressure measurements for a period of time are then statistically analyzed to identify standard deviation of the pressure measurement samples that occur during the time period immediately following the move to the RTD position.
Referring to
According to another embodiment of the invention, the method includes commanding movement of spool 156 and distal section 258 to ready to dispense position at step 405. The method further includes assessing the statistical measures taken during the time following the movement of the spool and the distal section to the ready to dispense position, including calculating a standard deviation for a plurality of time periods following a plurality of movements of the spool and distal section to the ready to dispense position 406 and determining an expected value for the standard deviation at step 408. The invention further includes identifying occasions wherein the standard deviation varies substantially from the expected value at step 410.
According to another embodiment, the invention includes associating the occasions wherein the standard deviation varies substantially from the expected value as being indicative of the flexible reservoir being filled to or near its maximum level or capacity at step 412. According to another embodiment of the invention, the method may include presenting a message that the flexible reservoir is filled to or near its maximum level or capacity at step 414. According to another embodiment, the method may include associating the flexible reservoir being filled to or near its maximum level or capacity with a risk that autodispensing may occur 416.
Occasions wherein the standard deviation vary substantially from the expected value can also in some embodiments indicate the effect of external factors such as transient temperature changes or mechanical pressure applied to ridged container 130. According to another embodiment of the invention, the method may include assessing statistical measures, including standard deviation for a plurality of time periods at step 418; determining an expected value for the standard deviation at step 420; and identifying occasions wherein the standard deviation vary substantially from the expected value at step 422.
According to another embodiment, the method may include associating the occasions wherein the standard deviation vary substantially from the expected value as being indicative of external factors including transient temperature changes and mechanical pressure applied to rigid container 130 identified in the flow chart as step 424 and rejecting measurements made on occasions when the standard deviation of the pressure measurements made during a selected period of time varies substantially from the expected value. A plurality of air pressure measurements are made during a selected period of time and averaged to determine an air pressure value for that period. A standard deviation is then calculated and compared to a preselected threshold or with the standard deviation of other average pressure values for other time periods. Average pressure measurements that have out of the norm standard deviations can be rejected. Alternatively, such measurements may be assigned a lesser weight, or significance, than measurements that are near the expected value at step 426.
According to another embodiment of the invention, the method includes commanding movement of main section 254 and distal section 258 to a filled position; commanding movement of main section 254 and distal section 258 from the filled position to a ready to dispense position; and commanding movement of main section 254 and distal section 258 from the ready to dispense position to a dispense position at step 428. The method may further include assessing the statistical measures for average pressure during a first time when main section 254 and distal section 258 are in the ready to fill position; assessing the statistical measures for average pressure during a second time when main section 254 and distal section 258 are in the ready to fill position; assessing the statistical measures for average pressure during a third time when main section 254 and distal section 258 are in the ready to dispense position; assessing the statistical measures for average pressure during a fourth time when main section 254 and distal section 258 are in the ready to dispense position for a period of time at step 430. The method may further include calculating three volume measurements of volume of the collapsible reservoir including a first insulin volume, a second insulin volume and a third insulin volume based on the average pressure measured by pressure sensor 158 during a first time period or interval, the average pressure measured by pressure sensor 158 during a second time period or interval, the average pressure during a third time period or interval and the average pressure measured by pressure sensor 158 during a fourth time period or interval at step 432 and comparing the first insulin volume, the second insulin volume and the third insulin volume to determine whether autodispensing has occurred at step 434.
According to another embodiment, the invention includes identifying a circumstance wherein the first insulin volume is greater than the second insulin volume and the second insulin volume is equal to the third insulin volume as being indicative of proper operation; further it may include identifying a circumstance wherein the first insulin volume is greater than the second insulin volume and the second insulin volume is greater than the third volume as being indicative that autodispensing has occurred at step 436.
According to another embodiment of the invention, the method may include presenting a message or warning that autodispensing has occurred if autodispensing has been identified at step 438.
According to another embodiment of the invention, the method further includes foregoing a future plan dispensing event if autodispensing has occurred at step 440.
According to another embodiment of the invention, a pressure measurement is taken by the pressure sensor 158 after distal section 258 and main section 254 are in the ready to dispense position for a period or interval of time. Under normal operating conditions, it is expected that there should be no change in volume. However, if autodispensing has occurred, a reduction in volume of the collapsible reservoir 126 will have occurred indicating that autodispensing has happened.
According to another embodiment of the invention, another volume measurement is determined after dispensing has occurred. Under normal conditions there will be little or no measurable change in volume of the collapsible reservoir during this dispensing, as distal section 258 remains stationary. However, if autodispensing has occurred, distal section 258 typically will be abutted against main section 254, and an increase of volume of collapsible reservoir 126 will occur as distal section 258 and main section 254 move toward distal end 238 together.
According to an embodiment of the invention, a first pressure measurement is taken when spool 156 and distal section 258 are at the RTF or filled position. This pressure is designated P1 P1 (also designated Prtf in Equation 1). Spool 156 and distal section 258 are then moved to the RTD position. This movement causes a change in volume referred to as Delta V1. A second pressure measurement is then taken when spool 156 and distal section 258 are at the RTD position. This pressure is designated P2 (also designated Prtd in Equations 1 and 3). Spool 156 is then moved from the RTD position to the dispensed position. This movement causes a change in volume referred to as Delta V2. A third pressure measurement is taken at the dispensed position. This pressure is designated P3 (also designated Pdispensed in Equation 3). Spool 156 and distal extension 258 are moved from the dispensed position back to the RTF position. A fourth pressure measurement is taken at the RTF position. This pressure is designated P4 (also designated Prtf in Equation 3).
With knowledge of the estimated pressures and volume changes, various calculations can be made.
A first estimate of air volume in the vented volume 160 can be estimated from P1, Delta V1 and P2. Once the air volume is known, fluid volume within the collapsible reservoir 126, fluid passages and the bore 220 can be estimated by subtraction of the air volume from the total known volume. The resulting fluid volume is designated Volume estimate1.
If the second pressure equals the third pressure (P2=P3) portable infusion pump system 110 may be generally considered to be operating properly because during normal dispensing the spool distal section 258 remains stationary during dispensing. If the second pressure is less than the third pressure (P2<P3) it can be inferred that either there is an occlusion in the fluid dispensing port 142 or line or that autodispensing has occurred. This is because the spool distal section 258 has moved distally thus increasing P3.
A second estimate of air volume in the vented volume 160 can be estimated from P3, Delta V2 and P4. Once the air volume is known, fluid volume within collapsible reservoir 126, fluid passages and bore 220 can be estimated by subtraction of the air volume from the total known volume. The resulting fluid volume is designated Volume estimate2.
Based on the above information the following can be estimated:
According to another embodiment, a persistence filter is included in the method so that the process is repeated a number of times before an inference is made that autodispensing has occurred or that an occlusion exists. If the process is repeated the designated number of times and it is inferred that autodispensing has occurred or that an occlusion exists, the method includes presenting a message, alarm or warning that that autodispensing has occurred or that an occlusion exists, as appropriate.
The present invention may be embodied in other specific forms without departing from the spirit of the essential attributes thereof; therefore, the illustrated embodiments should be considered in all respects as illustrative and not restrictive, reference being made to the appended claims rather than to the foregoing description to indicate the scope of the invention.
Patent | Priority | Assignee | Title |
10010674, | Feb 27 2009 | Tandem Diabetes Care, Inc. | Methods and devices for determination of flow reservoir volume |
10016169, | Apr 05 2012 | Welch Allyn, Inc. | Physiological parameter measuring platform device supporting multiple workflows |
10204081, | Apr 05 2012 | Welch Allyn, Inc. | Combined episodic and continuous parameter monitoring |
10226200, | Apr 05 2012 | Welch Allyn, Inc | User interface enhancements for physiological parameter monitoring platform devices |
10258736, | May 17 2012 | Tandem Diabetes Care, Inc. | Systems including vial adapter for fluid transfer |
10279107, | Aug 20 2015 | TANDEM DIABETES CARE, INC | Drive mechanism for infusion pump |
11039797, | Apr 05 2012 | Welch Allyn, Inc. | Physiological parameter measuring platform device |
11147916, | Aug 20 2015 | Tandem Diabetes Care, Inc. | Drive mechanism for infusion pump |
11278661, | Mar 10 2020 | Beta Bionics, Inc | Infusion system and components thereof |
11331463, | Jul 08 2015 | Trustees of Boston University | Infusion system and components thereof |
11357911, | Oct 24 2013 | Trustees of Boston University | Infusion pump and system for preventing mischanneling of multiple medicaments |
11458246, | Feb 05 2018 | TANDEM DIABETES CARE, INC | Methods and systems for detecting infusion pump conditions |
11571507, | Jul 16 2019 | Beta Bionics, Inc | Ambulatory device and components thereof |
11633535, | Jul 16 2019 | Beta Bionics, Inc | Ambulatory device and components thereof |
11771821, | Jan 06 2017 | Trustees of Boston University; BETA BIONICS, Inc. | Infusion system and components thereof |
12115338, | Mar 10 2020 | BETA BIONICS, Inc. | Infusion system and components thereof |
9750871, | May 17 2012 | TANDEM DIABETES CARE, INC | Pump device with multiple medicament reservoirs |
9962486, | Mar 14 2013 | Tandem Diabetes Care, Inc. | System and method for detecting occlusions in an infusion pump |
D772252, | Apr 05 2012 | Welch Allyn, Inc | Patient monitoring device with a graphical user interface |
D916713, | Apr 05 2012 | Welch Allyn, Inc. | Display screen with graphical user interface for patient central monitoring station |
ER8456, | |||
ER9763, |
Patent | Priority | Assignee | Title |
1274884, | |||
1866061, | |||
2412397, | |||
2971466, | |||
3023750, | |||
3153414, | |||
3202178, | |||
3302578, | |||
3493496, | |||
3596939, | |||
3838794, | |||
3985133, | May 28 1974 | ALARIS MEDICAL SYSTEMS, INC | IV pump |
4137913, | Feb 28 1975 | IVAC MEDICAL SYSTEMS, INC | Fluid flow control system |
4271989, | Mar 27 1979 | Physics International Company | Micro-metering system |
4314979, | Jul 29 1977 | PCUK Produits Chimiques Ugine Kuhlmann | Industrial process for continuous production of zeolite A |
4405294, | Oct 11 1980 | Dragerwerk AG | Dosing pump |
4416596, | Apr 09 1981 | Fluid-transfer system and method | |
4443218, | Sep 09 1982 | InSet Technologies Incorporated | Programmable implantable infusate pump |
4636226, | Aug 26 1985 | COMMAND U S INC | High pressure oxygen production system |
4673415, | May 22 1986 | COMMAND U S INC | Oxygen production system with two stage oxygen pressurization |
4808167, | Jan 16 1987 | MEDTRONIC MINIMED, INC | Medication infusion system with disposable pump/battery cassette |
4826482, | Mar 05 1987 | DEKA PRODUCTS LIMITED PARTNERSHIP, A LIMITED PARTNERSHIP OF NH | Enhanced pressure measurement flow control system |
4886499, | Dec 18 1986 | Hoffman-La Roche Inc | Portable injection appliance |
5096385, | Nov 08 1989 | CAREFUSION 303, INC | Method and system for upstream occlusion detection |
5170912, | Sep 07 1990 | ITT Manufacturing Enterprises, Inc | Proportioning pump |
5178603, | Jul 24 1990 | Baxter International, Inc.; Baxter International Inc | Blood extraction and reinfusion flow control system and method |
5192272, | Oct 26 1989 | Pack for administration of sterile liquids including pharmaceutical, nutrient and energy-source liquids | |
5215450, | Mar 14 1991 | Innovative pumping system for peristaltic pumps | |
5295976, | Apr 04 1990 | Eli Lilly and Company | Dose indicating injection pen |
5364242, | Nov 25 1992 | SMITHS MEDICAL ASD, INC | Pump apparatus and method including double activation pump apparatus |
5431171, | Jun 25 1993 | The Regents of the University of California | Monitoring fetal characteristics by radiotelemetric transmission |
5531697, | Apr 15 1994 | SMITHS MEDICAL ASD, INC | Systems and methods for cassette identification for drug pumps |
5531698, | Apr 15 1994 | SMITHS MEDICAL ASD, INC | Optical reflection systems and methods for cassette identification fordrug pumps |
5568806, | Feb 16 1995 | MEDTRONIC MINIMED, INC | Transcutaneous sensor insertion set |
5647854, | Apr 15 1994 | SMITHS MEDICAL ASD, INC | Base plate for a drug pump |
5704520, | Jul 19 1993 | Elan Corporation, PLC | Liquid material dispenser and valve |
5891097, | Aug 12 1994 | GS Yuasa Corporation | Electrochemical fluid delivery device |
5938636, | Jun 20 1997 | BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM, THE | Autoinfuser for resuscitation and method of infusion fluid injection |
5984894, | Apr 18 1991 | Novo Nordisk A S | Infuser |
5997501, | Nov 18 1993 | Alkermes Pharma Ireland Limited | Intradermal drug delivery device |
6093312, | Jan 22 1998 | Entre Pure, Inc. | Ice dispenser with an air-cooled bin |
6123686, | Apr 15 1994 | SMITHS MEDICAL ASD, INC | Systems and methods for cassette identification for drug pumps |
6213120, | Aug 21 1997 | Instrumentarium Corp | Device and method for determining gas volume and volumetric changes in a ventilator |
6280408, | Nov 09 1992 | Controlled fluid transfer system | |
6368314, | Sep 08 1998 | Roche Diabetes Care, Inc | Monitoring of the pressure of a product fluid to be administered in dosed amounts during infusion or injection |
6413238, | Sep 17 1999 | Baxter International Inc | Fluid dispenser with stabilized fluid flow |
6458102, | May 28 1999 | MEDTRONIC MINIMED, INC | External gas powered programmable infusion device |
6520936, | Jun 08 1999 | MEDTRONIC MINIMED, INC | Method and apparatus for infusing liquids using a chemical reaction in an implanted infusion device |
6641533, | Aug 18 1998 | Medtronic MiniMed, Inc. | Handheld personal data assistant (PDA) with a medical device and method of using the same |
6641562, | May 10 2000 | HPS Medical, Inc. | Apparatus and method of intravenous fluid infusion |
6676387, | Jun 07 1999 | Tremco Incorporated | Metering pump with a rotary valve responsive to electrical signals from the contact between a fluid responsive shuttle and dual probes |
6743201, | Apr 01 1998 | Fresenius Medical Care Deutschland GmbH | Cassette for delivering fluids, especially dialysis fluids |
6749587, | Feb 22 2002 | INSULET CORPORATION | Modular infusion device and method |
6810290, | Jan 21 2000 | MEDTRONIC MINIMED, INC | Ambulatory medical apparatus with hand held communication device |
6974115, | Dec 11 2002 | Young & Franklin Inc. | Electro-hydrostatic actuator |
7008403, | Jul 19 2002 | TANDEM DIABETES CARE, INC | Infusion pump and method for use |
7029455, | Sep 08 2000 | INSULET CORPORATION | Devices, systems and methods for patient infusion |
7107706, | Aug 14 1997 | ProMDX Technology, Inc. | Ergonomic systems and methods providing intelligent adaptive surfaces and temperature control |
7220109, | Jan 08 2003 | CITIBANK, N A , AS ADMINISTRATIVE AND COLLATERAL AGENT | Pump cylinder seal |
722431, | |||
7231263, | May 23 2003 | Method for controlling insulin pump through internet | |
7232435, | Feb 06 2004 | Medtronic, Inc | Delivery of a sympatholytic cardiovascular agent to the central nervous system to counter heart failure and pathologies associated with heart failure |
7244225, | Oct 07 2003 | BRIDGEPORT NETWORKS, INC | Devices and methods for non-invasively improving blood circulation |
7338464, | Mar 01 2001 | Advanced Neuromodulation Systems, Inc. | Non-constant pressure infusion pump |
7341581, | Jul 19 2002 | TANDEM DIABETES CARE, INC ; TANDEM DIABETS CARE, INC | Infusion pump and method for use |
7374556, | Jul 19 2002 | TANDEM DIABETES CARE, INC | Infusion pump and method for use |
7390311, | Jul 30 2004 | Medtronic, Inc. | Delivery of a sympatholytic cardiovascular agent to the central nervous system |
7407490, | Nov 29 2001 | Novo Nordisk A S | Delivery device and cartridge therefore |
7811279, | Jul 16 2003 | Programmable medical drug delivery systems and methods for delivery of multiple fluids and concentrations | |
7922462, | Mar 30 2004 | Novo Nordisk A S | Actuator system comprising lever mechanism |
7935104, | Apr 03 2006 | Roche Diabetes Care, Inc | Systems and methods for sustained medical infusion and devices related thereto |
7963945, | Dec 14 2005 | Hewlett-Packard Development Company, L.P. | Replaceable supplies for IV fluid delivery systems |
7967022, | Feb 27 2007 | DEKA Products Limited Partnership | Cassette system integrated apparatus |
8002747, | May 26 2005 | MEDTRONIC MINIMED, INC | Implantable infusion device with multiple controllable fluid outlets |
8032226, | Sep 07 2007 | INSULET CORPORATION | User profile backup system for an infusion pump device |
8056582, | Aug 08 2008 | TANDEM DIABETES CARE, INC | System of stepped flow rate regulation using compressible members |
8062257, | Oct 29 1998 | Medtronic MiniMed, Inc. | Method and apparatus for detecting occlusions in an ambulatory infusion pump |
8066629, | Feb 24 2005 | Ethicon Endo-Surgery, Inc | Apparatus for adjustment and sensing of gastric band pressure |
8094009, | Aug 27 2008 | Biolinq Incorporated | Health-related signaling via wearable items |
8100842, | Sep 26 2004 | TYLERTON INTERNATIONAL INC | Portable device for the enhancement of circulation |
8105265, | Oct 12 2007 | DEKA Products Limited Partnership | Systems, devices and methods for cardiopulmonary treatment and procedures |
8285328, | Apr 20 2010 | MINIPUMPS, LLC | Remote-controlled drug pump devices |
8287495, | Jul 30 2009 | Tandem Diabetes Care, Inc. | Infusion pump system with disposable cartridge having pressure venting and pressure feedback |
8292876, | Oct 15 2008 | BioQ Pharma Incorporated | Special purpose fluid dispenser with pre-filled reservoir |
8298183, | Mar 31 2006 | DEBIOTECH S A | Medical liquid injection device |
8298184, | Jul 30 2009 | Tandem Diabetes Care, Inc. | Infusion pump system with disposable cartridge having pressure venting and pressure feedback |
8328754, | Sep 07 2007 | INSULET CORPORATION | Activity sensing techniques for an infusion pump system |
8408421, | Sep 16 2008 | TANDEM DIABETES CARE, INC | Flow regulating stopcocks and related methods |
20010027791, | |||
20020040208, | |||
20020072733, | |||
20030032930, | |||
20030216683, | |||
20040122353, | |||
20040204673, | |||
20040260233, | |||
20050004514, | |||
20060150747, | |||
20060150748, | |||
20060206054, | |||
20060229557, | |||
20060271022, | |||
20070112301, | |||
20070118405, | |||
20070250007, | |||
20070264130, | |||
20080029173, | |||
20080051716, | |||
20080058697, | |||
20080092969, | |||
20080196762, | |||
20080234637, | |||
20090026146, | |||
20090069785, | |||
20090191067, | |||
20090192724, | |||
20090217982, | |||
20090254037, | |||
20090270833, | |||
20090275896, | |||
20090287180, | |||
20100008795, | |||
20100028208, | |||
20100032041, | |||
20100036327, | |||
20100065578, | |||
20100065579, | |||
20100094114, | |||
20100096019, | |||
20100192686, | |||
20100218586, | |||
20100324394, | |||
20110060280, | |||
20110120206, | |||
20110144586, | |||
20110144616, | |||
20110152770, | |||
20110152824, | |||
20110160654, | |||
20110166544, | |||
20110319862, | |||
20120029433, | |||
20120029468, | |||
20120029708, | |||
20120030610, | |||
20130053816, | |||
20130150766, | |||
20130204542, | |||
20130306191, | |||
20130324928, | |||
20140039392, | |||
20140039805, | |||
D433755, | Feb 25 1999 | MEDTRONIC MINIMED, INC | Glucose sensor |
D598109, | Aug 27 2008 | DEKA Products Limited Partnership | Graphical user interface module for patient-operated medical device |
D613411, | Aug 27 2008 | DEKA Products Limited Partnership | Graphical user interface module for patient-operated medical device |
EP272530, | |||
RE41956, | Sep 16 1999 | Novo Nordisk A/S | Dose setting limiter |
RE42682, | Aug 01 1996 | Medtronic, Inc. | RF coupled, implantable medical device with rechargeable back-up power source |
RE42958, | Oct 07 2003 | CARDIOMAX, LLC | Devices and methods for non-invasively improving blood circulation |
WO130422, | |||
WO2004009160, | |||
WO2007065944, | |||
WO2008024812, | |||
WO2009016636, | |||
WO2009044221, | |||
WO2012019726, | |||
WO9532013, |
Executed on | Assignor | Assignee | Conveyance | Frame | Reel | Doc |
Mar 15 2013 | Tandem Diabetes Care, Inc. | (assignment on the face of the patent) | / | |||
May 30 2013 | MICHAUD, MICHAEL | TANDEM DIABETES CARE, INC | ASSIGNMENT OF ASSIGNORS INTEREST SEE DOCUMENT FOR DETAILS | 030686 | /0849 | |
Apr 04 2014 | TANDEM DIABETES CARE, INC | CAPITAL ROYALTY PARTNERS II - PARALLEL FUND A L P | SHORT-FORM PATENT SECURITY AGREEMENT | 032608 | /0780 | |
Apr 04 2014 | TANDEM DIABETES CARE, INC | PARALLEL INVESTMENT OPPORTUNITIES PARTNERS II L P | SHORT-FORM PATENT SECURITY AGREEMENT | 032608 | /0780 | |
Apr 04 2014 | TANDEM DIABETES CARE, INC | CAPITAL ROYALTY PARTNERS II CAYMAN L P | SHORT-FORM PATENT SECURITY AGREEMENT | 032608 | /0780 | |
Apr 04 2014 | TANDEM DIABETES CARE, INC | CAPITAL ROYALTY PARTNERS II L P | SHORT-FORM PATENT SECURITY AGREEMENT | 032608 | /0780 | |
Aug 08 2018 | CAPITAL ROYALTY PARTNERS II CAYMAN L P | TANDEM DIABETES CARE, INC | RELEASE BY SECURED PARTY SEE DOCUMENT FOR DETAILS | 046761 | /0843 | |
Aug 08 2018 | PARALLEL INVESTMENT OPPORTUNITIES PARTNERS II L P | TANDEM DIABETES CARE, INC | RELEASE BY SECURED PARTY SEE DOCUMENT FOR DETAILS | 046761 | /0843 | |
Aug 08 2018 | CAPITAL ROYALTY PARTNERS II L P - PARALLEL FUND A L P | TANDEM DIABETES CARE, INC | RELEASE BY SECURED PARTY SEE DOCUMENT FOR DETAILS | 046761 | /0843 | |
Aug 08 2018 | CAPITAL ROYALTY PARTNERS II L P | TANDEM DIABETES CARE, INC | RELEASE BY SECURED PARTY SEE DOCUMENT FOR DETAILS | 046761 | /0843 | |
May 18 2022 | TANDEM DIABETES CARE, INC | BANK OF AMERICA, N A , AS ADMINISTRATIVE AGENT | SECURITY INTEREST SEE DOCUMENT FOR DETAILS | 060179 | /0100 | |
Mar 19 2024 | BANK OF AMERICA, N A , AS ADMINISTRATIVE AGENT | TANDEM DIABETES CARE, INC | RELEASE BY SECURED PARTY SEE DOCUMENT FOR DETAILS | 066880 | /0918 |
Date | Maintenance Fee Events |
Apr 29 2019 | M1551: Payment of Maintenance Fee, 4th Year, Large Entity. |
May 03 2023 | M1552: Payment of Maintenance Fee, 8th Year, Large Entity. |
Date | Maintenance Schedule |
Nov 10 2018 | 4 years fee payment window open |
May 10 2019 | 6 months grace period start (w surcharge) |
Nov 10 2019 | patent expiry (for year 4) |
Nov 10 2021 | 2 years to revive unintentionally abandoned end. (for year 4) |
Nov 10 2022 | 8 years fee payment window open |
May 10 2023 | 6 months grace period start (w surcharge) |
Nov 10 2023 | patent expiry (for year 8) |
Nov 10 2025 | 2 years to revive unintentionally abandoned end. (for year 8) |
Nov 10 2026 | 12 years fee payment window open |
May 10 2027 | 6 months grace period start (w surcharge) |
Nov 10 2027 | patent expiry (for year 12) |
Nov 10 2029 | 2 years to revive unintentionally abandoned end. (for year 12) |